Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're feeling unwell while taking Mounjaro, the question of what to do with your injection is a reasonable one — and the answer matters clinically. Vomiting, diarrhoea and reduced fluid intake can all affect how your body tolerates tirzepatide, and the NHS guidance on tirzepatide is clear that dehydration during a GI illness is the main risk to manage. This page sets out the key sick day principles drawn from official UK guidance, so you know what to watch for and when to get help. These are general principles — your prescriber and the Patient Information Leaflet in your box are the right sources for decisions about your specific dose and situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) slows gastric emptying and reduces appetite, both part of how it supports weight loss. On a normal day those effects are manageable. During a stomach bug or fever, though, they interact with the illness itself in a way that matters. Nausea and vomiting are already among the most common side effects at the start of treatment or after a dose increase, as the NHS tirzepatide medicines page notes. Add an unrelated illness on top and the result can be significantly reduced fluid intake at exactly the point your body is losing more through vomiting or loose stools.
Dehydration is the central concern. Even mild fluid loss can become concentrated quickly if eating and drinking are difficult, and in rare cases this has led to kidney problems associated with GLP-1 use. The practical priority during any sick day is hydration, small, frequent sips of water or an oral rehydration solution rather than large amounts at once, which the stomach is less likely to tolerate. If you genuinely cannot keep fluids down over several hours, that is a reason to seek medical advice rather than wait it out.
It is also worth knowing that any medicine you take for the illness (painkillers, antacids, rehydration salts) may be absorbed differently while your gut is under stress. Always check with a pharmacist before combining over-the-counter treatments with your prescription.
The guidance on being sick while on Mounjaro does not point to a single universal rule. What the Patient Information Leaflet does say, clearly, is that if you miss a dose for any reason (illness included) you should take it as soon as possible within four days of the scheduled day. After four days have passed, skip that dose entirely and resume your usual weekly schedule. Never take two doses in one week to make up for a missed one. The leaflet is the authoritative source here because the exact instruction can vary by strength; always check the one packaged with your current pen.
Whether it is sensible to inject during an acute illness is a clinical question. If you are vomiting severely and already struggling with dehydration, adding a dose that further slows gastric emptying may worsen symptoms temporarily. That is the kind of nuanced decision a prescriber can help you make based on how you are actually feeling, not something to guess at. If you are mildly under the weather but managing fluids adequately, most people find their scheduled injection is fine to take. The difference between those two scenarios is why the answer is never just yes or no.
Anyone experiencing side effects that feel unusually severe during an illness should not assume they are routine. Call your GP or contact NHS 111 if you are unsure.
Some symptoms need medical attention promptly, regardless of whether you assume they are linked to Mounjaro or to a passing bug. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 receptor agonist medicines specifically highlighting acute pancreatitis, a serious, though infrequent, risk. The symptom to know is severe, persistent stomach pain that does not ease and may spread toward the back, sometimes alongside vomiting. This is distinct from the ordinary nausea that many people feel in their first few weeks on treatment.
Other symptoms that warrant prompt help: signs of dehydration that are not responding to sips of fluid (dizziness when standing, very dark urine, confusion), any allergic reaction, and pain in the upper right abdomen that could suggest a gallbladder problem. If you are uncertain whether what you are experiencing fits one of these patterns, err on the side of ringing ahead, a pharmacist or NHS 111 can help you assess it without an appointment.
You can also report any suspected side effect, including one you are unsure about, through the MHRA's Yellow Card scheme. Reports from real patients genuinely shape the ongoing safety profile of medicines like tirzepatide.
Most people recover from an intercurrent illness and return to their Mounjaro schedule without complication. The practical steps that help are straightforward: rest, hydrate consistently, and check the PIL for the missed-dose window if the illness fell on or near your injection day. If you are well enough to eat by the time your next dose is due and your four-day window has not passed, most prescribers would advise continuing as planned.
If you lost a significant amount of weight very quickly during the illness (common with a severe stomach bug) mention it at your next prescriber review. Rapid short-term weight changes during illness are different from treatment-related loss, and a prescriber may want to note it in your record.
People who experience persistent nausea beyond a single sick day (not linked to an acute illness but as an ongoing feature of treatment) often find that specific strategies for managing nausea on Mounjaro can make a real difference, including meal timing, portion size and food choices. The pattern of side effects in the first days after an injection also tends to follow a predictable rhythm, which can help you distinguish treatment-related symptoms from something unrelated.
The cost and logistics of managing a prescription during a difficult patch are worth thinking through. If you have questions about how treatment continuity is handled at our pharmacy, or want a broader look at how private Mounjaro treatment is priced in the UK, those pages have the detail. For personal guidance on sick days and your specific situation, speaking to our prescribers is the clearest route forward, and aftercare support is included as standard, seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.